Bank of America’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-838,685
| Closed | -$99.3M | – | 8448 |
|
|
2021
Q1 | $99.3M | Sell |
838,685
-12,836
| -2% | -$1.52M | 0.01% | 896 |
|
|
2020
Q4 | $101M | Sell |
851,521
-91,438
| -10% | -$10.6M | 0.01% | 782 |
|
|
2020
Q3 | $105M | Buy |
942,959
+39,988
| +4% | +$4.29M | 0.01% | 715 |
|
|
2020
Q2 | $92.3M | Sell |
902,971
-11,846
| -1% | -$1.27M | 0.01% | 728 |
|
|
2020
Q1 | $98.7M | Buy |
914,817
+25,231
| +3% | +$2.9M | 0.02% | 636 |
|
|
2019
Q4 | $104M | Buy |
889,586
+48,291
| +6% | +$5.59M | 0.01% | 751 |
|
|
2019
Q3 | $96.3M | Buy |
841,295
+15,037
| +2% | +$1.5M | 0.01% | 753 |
|
|
2019
Q2 | $78.7M | Sell |
826,258
-272,971
| -25% | -$25.7M | 0.01% | 857 |
|
|
2019
Q1 | $100M | Buy |
1,099,229
+222,588
| +25% | +$18.2M | 0.02% | 736 |
|
|
2018
Q4 | $66.5M | Sell |
876,641
-448,579
| -34% | -$33M | 0.01% | 847 |
|
|
2018
Q3 | $106M | Buy |
1,325,220
+673,959
| +103% | +$62.8M | 0.02% | 697 |
|
|
2018
Q2 | $64.7M | Buy |
651,261
+107,573
| +20% | +$9.29M | 0.01% | 931 |
|
|
2018
Q1 | $44M | Buy |
543,688
+533,930
| +5,472% | +$43.2M | 0.01% | 1137 |
|
|
2017
Q4 | $769K | Sell |
9,758
-950
| -9% | -$79K | ﹤0.01% | 4657 |
|
|
2017
Q3 | $988K | Sell |
10,708
-33,622
| -76% | -$3.23M | ﹤0.01% | 4514 |
|
|
2017
Q2 | $5.01M | Sell |
44,330
-11,788
| -21% | -$1.32M | ﹤0.01% | 3028 |
|
|
2017
Q1 | $5.62M | Buy |
56,118
+22,583
| +67% | +$2.41M | ﹤0.01% | 2909 |
|
|
2016
Q4 | $3.61M | Sell |
33,535
-114,138
| -77% | -$13.3M | ﹤0.01% | 3258 |
|
|
2016
Q3 | $18.4M | Buy |
147,673
+95,711
| +184% | +$11.3M | ﹤0.01% | 1706 |
|
|
2016
Q2 | $5.52M | Sell |
51,962
-20,369
| -28% | -$2.37M | ﹤0.01% | 2728 |
|
|
2016
Q1 | $8.28M | Buy |
72,331
+20,272
| +39% | +$2.38M | ﹤0.01% | 2324 |
|
|
2015
Q4 | $7.42M | Sell |
52,059
-6,817
| -12% | -$787K | ﹤0.01% | 2553 |
|
|
2015
Q3 | $5.29M | Buy |
58,876
+52,567
| +833% | +$5.55M | ﹤0.01% | 2826 |
|
|
2015
Q2 | $726K | Buy |
6,309
+492
| +8% | +$51.7K | ﹤0.01% | 4387 |
|
|
2015
Q1 | $555K | Buy |
5,817
+440
| +8% | +$32.9K | ﹤0.01% | 4233 |
|
|
2014
Q4 | $361K | Buy |
5,377
+563
| +12% | +$34.9K | ﹤0.01% | 4904 |
|
|
2014
Q3 | $260K | Buy |
4,814
+3,913
| +434% | +$193K | ﹤0.01% | 5155 |
|
|
2014
Q2 | $40K | Buy |
901
+1
| +0.1% | +$41 | ﹤0.01% | 6817 |
|
|
2014
Q1 | $31K | Buy |
900
+800
| +800% | +$25.5K | ﹤0.01% | 6704 |
|
|
2013
Q4 | $3K | Hold |
100
| – | – | ﹤0.01% | 7595 |
|
|
2013
Q3 | $3K | Buy |
+100
| New | +$2.49K | ﹤0.01% | 7576 |
|
Bank of America's CBPO Position: Q2 2021 in Review
Bank of America sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 838,685 shares — an estimated $99.3M sold.
Bank of America first reported a position in CBPO in Q3 2013 and held it in 31 quarters. The position peaked at $106M in Q3 2018. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Bank of America reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Bank of America sold 838,685 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $99.3M.
- Bank of America first reported a position in China Biologic Products Holdings, Inc. in Q3 2013 and held it in 31 quarters.
- Bank of America's China Biologic Products Holdings, Inc. position peaked at $106M in Q3 2018.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Bank of America's 13F filing for Q2 2021, filed 16 Aug 2021.